Ticker Details
Terns Pharmaceuticals, Inc.
IPO Date:	February 1, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.27B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.37 | 4.09%
Avg Daily Range (30 D):	$0.95 | 2.58%
Avg Daily Range (90 D):	$1.01 | 3.66%

Institutional Daily Volume
Avg Daily Volume:	.74M
Avg Daily Volume (30 D):	1.75M
Avg Daily Volume (90 D):	3.01M

Trade Size
Avg Trade Size (Sh.):	102
Avg Trade Size (Sh.) (30 D):	65
Avg Trade Size (Sh.) (90 D):	85

Institutional Trades
Total Institutional Trades:	1,093
Avg Institutional Trade:	$2.63M
Avg Institutional Trade (30 D):	$3.29M
Avg Institutional Trade (90 D):	$3.48M
Avg Institutional Trade Volume:	.18M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.21M
Avg Closing Trade (30 D):	$6.32M
Avg Closing Trade (90 D):	$7.61M
Avg Closing Volume:	210.22K

News

Feb 20, 2026 @ 5:02 AM ORBIMED Advisors Trims $125 Million Terns Stake Af... Source: Eric Trie

Feb 17, 2026 @ 5:32 PM Fund Discloses $35 Million Biotech Buy Amid Stagge... Source: Jonathan Ponciano

Dec 10, 2025 @ 4:30 AM Terns Announces Pricing of Upsized $650 Million Pu... Source: Terns Pharmaceuticals

Dec 8, 2025 @ 7:45 PM Terns Highlights Additional Positive Phase 1 Clini... Source: Terns Pharmaceuticals

Dec 3, 2025 @ 2:11 PM Terns Stock Surges 300% in One Year — What ... Source: Jonathan Ponciano

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-1.02	$-.27	$-.26
Diluted EPS	$-1.02	$-.27	$-.26
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-94.44M	$-24.64M	$-24.09M
Operating Income / Loss	$-108.48M	$-27.72M	$-27.38M
Cost of Revenue
Net Cash Flow	$-119.44M	$4.73M	$6.94M
PE Ratio